NCT04319848View on ClinicalTrials.gov

Safety and Efficacy of Tissue Engineered Endothelial Keratoplasty

PHASE1RecruitingINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

December 1, 2017

Primary Completion Date

December 31, 2027

Study Completion Date

June 30, 2028

Conditions
Mild to Moderate Corneal Endothelial DecompensationBullous KeratopathyFuchs' Endothelial DystrophyPost-surgical Corneal Decompensation (Irreversible)
Interventions
OTHER

TE-EK treatment group

Transplantation of tissue-engineered endothelial graft through DSAEK procedure.

Trial Locations (1)

Unknown

RECRUITING

Singapore Eye Research Institute, Singapore

All Listed Sponsors
lead

Singapore Eye Research Institute

OTHER